Robert Mazzola
34Patents
6h-index
129Co-inventors
68Inventor score
Filing activity: Dec 19, 2002 → Nov 5, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7763609B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 34 | Active |
| US7592348B2 | Heterocyclic aspartyl protease inhibitors | Emerging Cross-Sectional Technologies | 14 | Active |
| US8691831B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 7 | Active |
| US10329289B2 | 6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 7 | Active |
| US8691833B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 7 | Active |
| US8829036B2 | Heterocyclic aspartyl protease inhibitors | Human Necessities | 7 | Active |
| US7700603B2 | Heterocyclic aspartyl protease inhibitors | Chemistry; Metallurgy | 6 | Active |
| US10351564B2 | 6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 6 | Active |
| US6838466B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7973067B2 | Heterocyclic aspartyl protease inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8518975B2 | Gamma secretase modulators | Chemistry; Metallurgy | 4 | Active |
| US8927559B2 | Quinazolinone-type compounds as CRTH2 antagonists | Chemistry; Metallurgy | 4 | Active |
| US7652020B2 | Compounds for the treatment of inflammatory disorders | Chemistry; Metallurgy | 3 | Expired |
| US10933056B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 2 | Active |
| US8168641B2 | Aspartyl protease inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8242112B2 | Heterocyclic aspartyl protease inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10945771B2 | Azabicyclo[4.1.0]heptane allosteric modulators of the M4 muscarinic acetylcholine receptor | Human Necessities | 1 | Active |
| US11149036B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 1 | Active |
| US8357682B2 | Gamma secretase modulators | Chemistry; Metallurgy | 1 | Active |
| US8629155B2 | Aspartyl protease inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10836775B2 | 6,6-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor | Chemistry; Metallurgy | 1 | Active |
| US8722708B2 | Substituted isoindolines as aspartyl protease inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9469615B2 | Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US7879997B2 | Compounds for the treatment of inflammatory disorders | Human Necessities | 0 | Active |
| US7598242B2 | Compounds for the treatment of inflammatory disorders | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.